This study sought to identify abnormalities in the levels of iron transport
proteins in patients with superficial siderosis of the central nervous sys
tem. We compared patients with superficial siderosis (n = 7) with patients
suffering from various other neurological disorders (n = 176, total). CSF a
nd serum levels of lactoferrin, and CSF levels of transferrin were measured
by enzyme-linked immunosorbent assay. Serum transferrin was measured by ne
phelometry. Lactoferrin, but not transferrin, levels in the CSF were signif
icantly elevated in superficial siderosis. Unexpectedly, CSF transferrin wa
s decreased in multiple sclerosis patients. Enhanced CSF lactoferrin may re
flect an increased iron transport requirement in the central nervous system
in superficial siderosis and might be a useful measure for monitoring resp
onse to therapy.